Contract manufacturing roundtable: part two

CDMOs are operating in an increasingly competitive marketplace, with new challenges emerging as a result of more complex pharmaceutical products entering the supply chain, evolving patient needs and regulatory changes.

Following the first part of the Manufacturing Chemist roundtable, which focussed on industry trends and the expectations surrounding contract partners’ service offerings, our CEO, Anthony Sheehan, discusses the major challenges faced by CDMOs and what we can expect to see in the near future. Read the second half of the roundtable here:

Did our portfolio meet your needs? Let´s discuss starting business with us.

Contact us